Beximco Pharmaceuticals Limited (BXP) is a leading drug manufacturers-specialty & generic business based in the UK. It opened the day at 99.5p after a previous close of 103.25p. During the day the price has varied from a low of 99.5p to a high of 103.25p. The latest price was 103.5p (25 minute delay). Beximco Pharmaceuticals is listed on the London Stock Exchange (LSE) and employs 4,500 staff. All prices are listed in pence sterling.
Since the stock market crash in March caused by coronavirus, Beximco Pharmaceuticals's share price has had significant positive movement.
Its last market close was 58.5p, which is 32.87% up on its pre-crash value of 39.27p (accounting for the 23 November 2020 split) and 108.41% up on the lowest point reached during the March crash when the shares fell as low as 28.07p (accounting for the 23 November 2020 split).
If you had bought £1,000 worth of Beximco Pharmaceuticals shares at the start of February 2020, those shares would have been worth £797.62 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £1,532.14.
|52-week range||27.7064p - 104.7499p|
|50-day moving average||86.6216p|
|200-day moving average||56.3053p|
|Wall St. target price||84p|
|Dividend yield||0.01p (1.32%)|
|Earnings per share (TTM)||N/A|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2021-01-15)||6.15%|
|1 month (2020-12-22)||2.22%|
|3 months (2020-10-22)||94.62%|
|6 months (2020-07-22)||174.34%|
|1 year (2020-01-22)||177.68%|
|2 years (2019-01-22)||147.50%|
|3 years (2018-01-22)||94.62%|
|5 years (2016-01-22)||346.47%|
Valuing Beximco Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Beximco Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Beximco Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 13x. In other words, Beximco Pharmaceuticals shares trade at around 13x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Gross profit TTM||£11.8 billion|
|Return on assets TTM||7.04%|
|Return on equity TTM||11.63%|
|Market capitalisation||£668.6 million|
TTM: trailing 12 months
Dividend payout ratio: 18.27% of net profits
Recently Beximco Pharmaceuticals has paid out, on average, around 18.27% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.32% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Beximco Pharmaceuticals shareholders could enjoy a 1.32% return on their shares, in the form of dividend payments. In Beximco Pharmaceuticals's case, that would currently equate to about 0.01p per share.
While Beximco Pharmaceuticals's payout ratio might seem low, this can signify that Beximco Pharmaceuticals is investing more in its future growth.
The latest dividend was paid out to all shareholders who bought their shares by 23 November 2020 (the "ex-dividend date").
Beximco Pharmaceuticals's shares were split on a 110:100 basis on 23 November 2020. So if you had owned 100 shares the day before before the split, the next day you'd have owned 110 shares. This wouldn't directly have changed the overall worth of your Beximco Pharmaceuticals shares – just the quantity. However, indirectly, the new 9.1% lower share price could have impacted the market appetite for Beximco Pharmaceuticals shares which in turn could have impacted Beximco Pharmaceuticals's share price.
Over the last 12 months, Beximco Pharmaceuticals's shares have ranged in value from as little as 27.7064p up to 104.7499p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Beximco Pharmaceuticals's is 0.5753. This would suggest that Beximco Pharmaceuticals's shares are less volatile than average (for this exchange).
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company offers allergic disorder, analgesic and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It provides its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was founded in 1976 and is headquartered in Dhaka, Bangladesh.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.